The relevance of donor T cell-directed immunoglobulin G in historic sera in the age of flow cytometry

被引:9
作者
Avlonitis, VS [1 ]
Chidambaram, V [1 ]
Manas, DM [1 ]
Cavanagh, G [1 ]
Carter, V [1 ]
Talbot, D [1 ]
机构
[1] Freeman Hosp, Liver Unit Off, Dept Liver & Renal Transplantat, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
关键词
D O I
10.1097/00007890-200010270-00026
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Renal transplant recipients with a positive historic cross-match due to donor T cell-directed IgG antibodies are considered to have decreased graft survival, even if their current serum is negative prior to transplantation, With the use of flow cytometric cross-match for testing current sera, false-negative results could be eliminated and the outcome of transplantation in this group of patients could be improved, assuming that immunological memory is effectively controlled with immunosupression. Methods. We reviewed our records to identify those patients who underwent cadaveric renal transplant, with a historic IgG positive cytotoxic T cell crossmatch and a current negative flow cytometric T cell cross-match. Results. Eighteen patients underwent cadaveric renal transplant in the face of a historic IgG positive T cell cross-match and a current negative flow cytometric T cell cross-match. In 14 patients treated with cyclosporine-based immunosuppression the 1-, 2-, and 3-year cumulative graft survival. rates were 57, 50, and 43%, respectively, Ten of the 14 patients (71%) ultimately lost their grafts. Conclusions, Even with negative flow cytometric crossmatch in current serum, a positive historic conventional cross-match suggests a high risk of graft failure.
引用
收藏
页码:1260 / 1263
页数:4
相关论文
共 11 条
[1]  
CARDELLA CJ, 1982, LANCET, V2, P1240
[2]  
FULLER TC, 1985, TRANSPLANT P, V17, P113
[3]   SUCCESSFUL TRANSPLANTATION OF CYCLOSPORINE-TREATED ALLOGRAFT RECIPIENTS WITH SEROLOGICALLY POSITIVE HISTORICAL, BUT NEGATIVE PREOPERATIVE, DONOR CROSSMATCHES [J].
KERMAN, RH ;
FLECHNER, SM ;
VANBUREN, CT ;
LORBER, MI ;
KAHAN, BD .
TRANSPLANTATION, 1985, 40 (06) :615-619
[4]   Cadaveric renal transplantation against a positive historic crossmatch under tacrolimus immunosuppression: Long-term follow-up [J].
Lyne, JC ;
Vivas, CA ;
Shapiro, R ;
Scantlebury, VP ;
Hakala, TR ;
Starzl, TE ;
Jordan, ML .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :312-312
[5]   REVERSAL OF STEROID-RESISTANT REJECTION IN RENAL-ALLOGRAFT RECIPIENTS USING FK506 [J].
MATHEW, A ;
TALBOT, D ;
MINFORD, EJ ;
RIX, D ;
STARKEY, G ;
FORSYTHE, JLR ;
PROUD, G ;
TAYLOR, RMR .
TRANSPLANTATION, 1995, 60 (10) :1182-1184
[6]  
MELZER JS, 1989, TRANSPL P, V21, P751
[7]   EFFECT OF ANTIIDIOTYPIC ANTIBODIES TO HLA ON GRAFT-SURVIVAL IN RENAL-ALLOGRAFT RECIPIENTS [J].
REED, E ;
HARDY, M ;
BENVENISTY, A ;
LATTES, C ;
BRENSILVER, J ;
MCCABE, R ;
REEMSTMA, K ;
KING, DW ;
SUCIUFOCA, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (23) :1450-1455
[8]   DIFFERENTIAL INHIBITION OF PRIMED ALLOREACTIVE CTLS IN-VITRO BY CLINICALLY USED CONCENTRATIONS OF CYCLOSPORINE AND FK506 [J].
ROELEN, DL ;
VANBREE, FPMJ ;
SCHANZ, U ;
VANROOD, JJ ;
CLAAS, FHJ .
TRANSPLANTATION, 1993, 56 (01) :190-195
[9]   IGG ANTIBODIES AGAINST AN HLA-ANTIGEN ARE ASSOCIATED WITH ACTIVATED CYTOTOXIC T-CELLS AGAINST THIS ANTIGEN, IGM ARE NOT [J].
ROELEN, DL ;
VANBREE, FPMJ ;
WITVLIET, MD ;
HABRAKEN, I ;
VANBEELEN, E ;
VANTSANT, PH ;
DEWAAL, LP ;
VANROOD, JJ ;
CLAAS, FHJ .
TRANSPLANTATION, 1994, 57 (09) :1388-1392
[10]  
Talbot D, 1993, Transpl Immunol, V1, P155, DOI 10.1016/0966-3274(93)90042-7